Lantheus (LNTH)
(Delayed Data from NSDQ)
$112.50 USD
+0.54 (0.48%)
Updated Oct 16, 2024 04:00 PM ET
After-Market: $112.50 0.00 (0.00%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$112.50 USD
+0.54 (0.48%)
Updated Oct 16, 2024 04:00 PM ET
After-Market: $112.50 0.00 (0.00%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
Factors That Make Centene (CNC) an Attractive Bet for Investors
by Zacks Equity Research
Centene (CNC) rides on continued top-line growth and numerous contract wins. Divestitures and an adequate cash-generating ability equip CNC well to invest in growth-related initiatives.
Molina Healthcare (MOH) Wins Medicaid Deal From Nebraska DHHS
by Zacks Equity Research
Molina Healthcare (MOH) clinches a contract from the Nebraska DHHS, through which the health insurer can efficiently serve the state's Medicaid members and boost its statewide presence.
Lantheus Holdings (LNTH) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Lantheus Holdings (LNTH) closed the most recent trading day at $67.39, moving +1.19% from the previous trading session.
Is First Trust Small Cap Core AlphaDEX ETF (FYX) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for FYX
Are Medical Stocks Lagging Lantheus (LNTH) This Year?
by Zacks Equity Research
Here is how Lantheus Holdings (LNTH) and argenex SE (ARGX) have performed compared to their sector so far this year.
3 Top Ranked Stocks for Exposure to the Medical Sector
by Shaun Pruitt
The healthcare business offers attractive defensive attributes that are so valuable in the current uncertain environment. As such, adding healthcare stocks to the portfolio brings much needed diversification.
4 Top-Performing Liquid Stocks for Attractive Returns in 2022
by Vaishali Doshi
Here are four top-ranked liquid stocks, Lantheus (LNTH), Cavco (CVCO), Pure Storage (PSTG) and Perion Network (PERI), which investors can add to their portfolio for returns.
Zacks.com featured highlights include Alliance Resource Partners, Digi International, MGP Ingredients, Lantheus and Carter Bankshares
by Zacks Equity Research
Alliance Resource Partners, Digi International, MGP Ingredients, Lantheus and Carter Bankshares have been highlighted in this Screen of The Week article.
A Simple System to Identify Winning Stocks in Volatile Markets
by Bryan Hayes
Following a system rather than relying on predictions is going to produce much more favorable results over time.
5 Stocks With Recent Price Strength in an Uncertain September
by Nalak Das
Investors target stocks that are witnessing a bullish run. Some of the stocks seeing price strength are MGPI, LNTH, CARE, ARLP and DGII.
Why Should You Add Ensign Group (ENSG) to Portfolio Now?
by Zacks Equity Research
Ensign Group (ENSG) benefits from a growing healthcare portfolio as a result of multiple facility buyouts. Solid cash-generating abilities empower ENSG to invest in growth-related initiatives.
Here's What Could Help Lantheus Holdings (LNTH) Maintain Its Recent Price Strength
by Zacks Equity Research
If you are looking for stocks that are well positioned to maintain their recent uptrend, Lantheus Holdings (LNTH) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.
Should You Invest in the Invesco S&P SmallCap Health Care ETF (PSCH)?
by Zacks Equity Research
Sector ETF report for PSCH
Factors that Make Humana (HUM) an Attractive Bet Now
by Zacks Equity Research
Humana (HUM) continues to gain on continued top-line growth resulting from its solid Medicaid and Medicare businesses. A strong cash position enables HUM to undertake growth-related investments.
Zacks.com featured highlights include Lantheus, Cavco, Globant and Perion Network
by Zacks Equity Research
Lantheus, Cavco, Globant and Perion Network are part of Zacks Screen of the Week article.
Bet on These 4 Top-Performing Liquid Stocks for Robust Returns
by Vaishali Doshi
Here are four top-ranked liquid stocks, Lantheus (LNTH), Cavco (CVCO), Globant (GLOB) and Perion Network (PERI), which investors can add to their portfolio for returns.
Here is What to Know Beyond Why Lantheus Holdings, Inc. (LNTH) is a Trending Stock
by Zacks Equity Research
Lantheus Holdings (LNTH) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Teladoc Health (TDOC) Ties Up to Upgrade RPM Care in Canada
by Zacks Equity Research
Teladoc Health (TDOC) teams up with Cloud DX to bring its virtual care capabilities to the latter's platform and dispense advanced RPM solutions to the Canadian residents.
Does Lantheus Holdings (LNTH) Have the Potential to Rally 26% as Wall Street Analysts Expect?
by Zacks Equity Research
The consensus price target hints at a 26.4% upside potential for Lantheus Holdings (LNTH). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Lantheus Holdings, Inc. (LNTH) Soars to 52-Week High, Time to Cash Out?
by Zacks Equity Research
Lantheus Holdings (LNTH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Is Trending Stock Lantheus Holdings, Inc. (LNTH) a Buy Now?
by Zacks Equity Research
Lantheus Holdings (LNTH) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Here's What Could Help Lantheus Holdings (LNTH) Maintain Its Recent Price Strength
by Zacks Equity Research
If you are looking for stocks that are well positioned to maintain their recent uptrend, Lantheus Holdings (LNTH) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.
4 Stocks to Watch Amid Recovering Medical Products Industry
by Indrajit Bandyopadhyay
Despite the COVID-induced challenges, rising demand for IVD coupled with dependence on AI & Robotics should lend support to the Zacks Medical-Products industry. ZBH, BIO, LNTH and HAE are well-poised to gain from the favorable factors.
Zacks.com featured highlights include Cadence Design Systems, Lantheus Holdings, Cavco Industries and Perion Network
by Zacks Equity Research
Cadence Design Systems, Lantheus Holdings, Cavco Industries and Perion Network are part of Zacks Screen of the Week article.
Snap Up These 4 Top-Ranked Liquid Stocks for Solid Gains
by Vaishali Doshi
Here are four top-ranked liquid stocks, Cadence Design Systems (CDNS), Lantheus (LNTH), Cavco (CVCO) and Perion Network (PERI), which investors can add to their portfolio for returns.